Drugs & medicalType II

pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Contamination

Read the official notice →
Date
2026-08-12
Country
Canada
Product
pms-IRBESARTAN 150 mg Tablet
Classification
Type II
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2026-08-13
  2. CA
    Drugs & medicalType II

    Portrait Core Services Cssxb

    Performance

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    IV Tubing Set Drip Chambers

    Performance

    Health CanadaOfficial notice →
  4. CA
  5. 2026-08-12
  6. CA
    Drugs & medicalType III

    Adequan I.M: Presence of particulate matter

    Product quality

    Health CanadaOfficial notice →
  7. 2026-08-11
  8. CA
    Drugs & medicalType II

    Semaglutide Injection: Incorrect Pen in Package

    Packaging

    Health CanadaOfficial notice →
  9. CA
    Drugs & medicalType II

    Omni-Tract Surgical Retractor System

    Sterility

    Health CanadaOfficial notice →
See all drugs & medical recalls →